Prognostic Significance of the Number of Postoperative Intraperitoneal Chemotherapy Cycles for Patients with Advanced Epithelial Ovarian Cancer

OBJECTIVE: Phase III trials have demonstrated a survival advantage for patients with optimally debulked epithelial ovarian cancer (EOC) who received intravenous (IV) and intraperitoneal (IP) chemotherapy compared to IV therapy alone. This was despite a significant proportion of patients in the IV/IP...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Gynecol Cancer
Egile Nagusiak: Suidan, Rudy S., Zhou, Qin, Iasonos, Alexia, O’Cearbhaill, Roisin E., Chi, Dennis S., Roche, Kara C. Long, Tanner, Edward J., Denesopolis, John, Barakat, Richard R., Zivanovic, Oliver
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4408230/
https://ncbi.nlm.nih.gov/pubmed/25664437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IGC.0000000000000389
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak